Literature DB >> 15852304

Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptase.

G Tachedjian1, J Radzio, N Sluis-Cremer.   

Abstract

The multifunctional enzyme human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a heterodimer composed of a 66-kDa (p66) subunit and a p66-derived 51-kDa (p51) subunit. p66/p51 HIV-1 RT contains 1 functional DNA polymerase and 1 ribonuclease H (RNase H) active site, which both reside in the p66 subunit at spatially distinct regions. In this study, we have investigated the relationship between the heterodimeric structure of HIV-1 RT and its enzymatic properties by introducing mutations at RT codon W401 that inhibit the formation of p66/p51 heterodimers. We demonstrate a striking correlation between abrogation of both HIV-1 RT dimerization and DNA polymerase activity. In contrast, the p66 monomers exhibited only moderately slowed catalytic rates of DNA polymerase-dependent and DNA polymerase-independent RNase H cleavage activity compared with the wild-type (WT) enzyme. Furthermore, no major changes in the unique cleavage patterns were observed between the WT and mutant enzymes for the different substrates used in the RNase H cleavage assays. Based on these results, and on our current understanding of HIV-1 RT structure, we propose that the p66 monomer can adopt an open tertiary conformation that is similar to that observed for the subunit in the heterodimeric enzyme. We also propose that the formation of intersubunit interactions in HIV-1 RT regulates the establishment of a functional DNA polymerase active site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852304     DOI: 10.1002/prot.20480

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  10 in total

1.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Efavirenz binding site in HIV-1 reverse transcriptase monomers.

Authors:  Valerie A Braz; Mary D Barkley; Rebecca A Jockusch; Patrick L Wintrode
Journal:  Biochemistry       Date:  2010-11-19       Impact factor: 3.162

3.  Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.

Authors:  Qing Xia; Jessica Radzio; Karen S Anderson; Nicolas Sluis-Cremer
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

4.  Impact of template overhang-binding region of HIV-1 RT on the binding and orientation of the duplex region of the template-primer.

Authors:  Alok K Upadhyay; Tanaji T Talele; Virendra N Pandey
Journal:  Mol Cell Biochem       Date:  2009-11-17       Impact factor: 3.396

5.  Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.

Authors:  Johanna Wapling; Katie L Moore; Secondo Sonza; Johnson Mak; Gilda Tachedjian
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.

Authors:  Dwight V Nissley; Jessica Radzio; Zandrea Ambrose; Chih-Wei Sheen; Noureddine Hamamouch; Katie L Moore; Gilda Tachedjian; Nicolas Sluis-Cremer
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

7.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

8.  Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.

Authors:  Anna Figueiredo; Katie L Moore; Johnson Mak; Nicolas Sluis-Cremer; Marie-Pierre de Bethune; Gilda Tachedjian
Journal:  PLoS Pathog       Date:  2006-11       Impact factor: 6.823

9.  Human semen contains exosomes with potent anti-HIV-1 activity.

Authors:  Marisa N Madison; Richard J Roller; Chioma M Okeoma
Journal:  Retrovirology       Date:  2014-11-19       Impact factor: 4.602

Review 10.  Structural Maturation of HIV-1 Reverse Transcriptase-A Metamorphic Solution to Genomic Instability.

Authors:  Robert E London
Journal:  Viruses       Date:  2016-09-27       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.